We recently released a list CHATGPT Stock Recommendations: Top 12 Stock Recommendations. In this article, we will explore the opposite position of Abbvie Inc. (NYSE:ABBV) from Chatgpt's other top stock recommendations.
After a 53% surge, the stock market was brought to the stock market in 2025, driven by uncertainty surrounding the escalating trade war. As of the end of the business on May 2, the broad market index fell 3.31% year by year.
Please read also: So far, the 11 worst performing stocks in S&P in 500 years and 15 Stock ChatGpt Forecasts May Make You Rich in 10 Years.
A New York-based investment banking company recently expects positive but depreciating returns in 2025. However, it added that the ongoing adoption of AI could lead to strong gatherings. The company also notes how the bull market history produces mediocre results in the third year, although usually not negative.
Over the past few decades, trends have also shown that sustained high returns are not common. After strong back-to-back performance in the 1920s, the market fell sharply in 1929, marking the beginning of the Great Depression. Then, after recovery in 1935 and 1936, they took a step back a year later.
Over the years, many investors have turned to Chatgpt for investment advice, including how the market will respond to headlines, Fed statements or any other event that could cause stock price movements. A 2023 survey showed that about 53% of millennials, 50% of Generation Z, and 46% of Generation X respondents used AI chatbots for investment advice.
By contrast, older Americans are found to be more suspicious of these suggestions, with only 25% of baby boomers using Chatgpt to buy stocks. Overall, about 47% of respondents used the platform for stock advice. 69% of them said they will also consider using Chatgpt for investment advice in the future.
While ChatGpt's reliability of providing accurate and up-to-date information has been repeatedly questioned by most financial analysts, a University of Florida professor claimed in 2023 that chatbots may be able to predict stock changes. Alejandro Lopez-Lira uses the platform to parse negative and positive titles of the stock and predict returns on the next day and is surprised to find the goodness of the results.
Whether tools like Chatgpt work in stock advice remains a debate. However, they are useful for new investors seeking financial education and companies they want to invest in.
Pharmacists distribute the drug to patients in pharmacies or chemists.
For this list, we prompt Chatppt to recommend the top 12 stocks based on its assessment of historical trends and current market conditions. These stocks are ranked in the same order as those provided by Chatgpt. The platform said its ranking is based on multiple factors including long-term performance, innovation capabilities, economic resilience and current macroeconomic trends.
From a perspective, we also shared hedge fund sentiment based on Insider Monkey's database, as of the fourth quarter of 2024.
Why are we interested in stocks that hedge funds to accumulate? The reason is simple: Our research shows that we can beat the market by mimicking the top stocks of the best hedge funds. Our strategy for quarterly newsletters selects 14 small and large stocks every quarter, returning 373.4% since May 2014, beating its benchmark by 218 percentage points (See more details here).
Number of hedge fund holders: 85
Abbvie Inc. (NYSE: ABBV) is a research-based biopharmaceutical company engaged in the manufacturing and sale of a variety of drugs and therapies. Its portfolio includes aesthetics, eye care, immunology, oncology, neuroscience and other key products. According to Chatgpt's stock advice, it is one of the best investment companies.
On April 25, Abbvie Inc. (NYSE: ABBV) announced impressive financial results in the first quarter of fiscal 2025, exceeding expectations in several of its therapeutic areas. The company reported a total net revenue of more than $13.3 billion, with an operating base growing by 9.8% since last year. It provided adjusted EPS of $2.46, up 6.5% year-on-year from the ABBV’s guidance midpoint, at 10 cents.
Abbvie Inc. (NYSE: ABBV) raised its adjusted EPS guide to $12.09 for the full year to $12.29, with an initial range of between $11.99 and $12.19 per share. Following the revenue call, Morgan Stanley raised its stock price target from $241 to $250 per share while maintaining its overweight rating.
Recent progress around positive waves at Abbvie Inc. (NYSE: ABBV) is FDA approval of Rinvoq (Upadacitinib) for the treatment of giant cell arthritis in adults. This is after the latest market authorization for the European Commission to treat adult patients.
Wall Street analysts are bullish by Abbvie Inc. (NYSE: ABBV) and have received a consensus buying rating, with an average stock price upside potential of nearly 7%. According to Insider Monkey's 4th quarter 2024 database, 85 hedge funds hold stakes in the company.
Overall, ABBV Ranked 11th In Chatgpt stock advice: Top 12 stock advice. Although we acknowledge the potential of ABBV as an investment, our belief is that AI stocks have greater hope to offer higher returns and be conducted in a shorter time frame. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for AI stocks that are more promising than ABBV but have less than 5 times its earnings, check out our report Cheapest AI stocks.
Read the next article: Buy 20 Best AI Stocks Now and According to the billionaire, there are now 30 best stocks
Disclosure: None. This article was originally published in Internal monkey.